Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Director
Fortier, Michelle

University Of California-Irvine
United States

Innovative Pain and Symptom Management Program for Children with Cancer 3R01CA222012-05S1 Alexis Bakos, Ph.D., M.P.H., R.N.
Friday, Bret E.B.

Essentia Institute Of Rural Health
United States

Essentia Health Community Cancer Research Program - NCORP 5UG1CA189812-09 Worta McCaskill-Stevens, M.D., M.S.
Geisler, Stefanie

Washington University
United States

Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy 5R37CA267905-02 PAR-19-325 (R01 Clinical Trial Optional) Alexis Bakos, Ph.D., M.P.H., R.N.
Geisler, Stefanie

Washington University
United States

Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy 5R37CA267905-02 PAR-19-325 (R01 Clinical Trial Optional) Alexis Bakos, Ph.D., M.P.H., R.N.
George, Suzanne

Alliance Nctn Foundation
United States

Alliance NCORP Research Base 3UG1CA189823-09S1 Worta McCaskill-Stevens, M.D., M.S.
Gewandter, Jennifer

University Of Rochester
United States

Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial 5R21CA235389-02 Marge Good, R.N., M.P.H., O.C.N.
Ghamande, Sharad A.

Augusta University
United States

Georgia CaRes 5UG1CA189851-09 Worta McCaskill-Stevens, M.D., M.S.
Golden, Carla B

Bay Area Tumor Institute
United States

Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites 5UG1CA189817-09 Worta McCaskill-Stevens, M.D., M.S.
Goode, Diana J

University Of New England
United States

Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy 1R01CA267554-01A1 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Alexis Bakos, Ph.D., M.P.H., R.N.
Grace, Peter M

University Of Tx Md Anderson Can Ctr
United States

PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain 5R01CA227064-05 Diane St Germain, R.N., M.S., C.R.N.P.